Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Keishi Yamasaki"'
Autor:
Kindness Lomotey Commey, Airi Enaka, Ryota Nakamura, Asami Yamamoto, Kenji Tsukigawa, Koji Nishi, Masaki Otagiri, Keishi Yamasaki
Publikováno v:
Toxins, Vol 16, Iss 7, p 316 (2024)
The characteristic accumulation of circulating uremic toxins, such as indoxyl sulfate (IS), in chronic kidney disease (CKD) further exacerbates the disease progression. The gut microbiota, particularly gut bacterial-specific enzymes, represents a sel
Externí odkaz:
https://doaj.org/article/b847bccec066409f99b9381cd3db9e67
Autor:
Kindness L. Commey, Airi Enaka, Ryota Nakamura, Asami Yamamoto, Kenji Tsukigawa, Koji Nishi, Daisuke Iohara, Fumitoshi Hirayama, Masaki Otagiri, Keishi Yamasaki
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 82 (2024)
Despite major improvements brought about by the introduction of taste-masked formulations of 4-phenylbutyrate (PB), poor compliance remains a significant drawback to treatment for some pediatric and dysphagic patients with urea cycle disorders (UCDs)
Externí odkaz:
https://doaj.org/article/339c5314131e47499ce83800b725a500
Autor:
Akito Kawai, Yoshihiro Kobashigawa, Kenshiro Hirata, Hiroshi Morioka, Shuhei Imoto, Koji Nishi, Victor Tuan Giam Chuang, Keishi Yamasaki, Masaki Otagiri
Publikováno v:
ACS Omega, Vol 7, Iss 34, Pp 29944-29951 (2022)
Externí odkaz:
https://doaj.org/article/2ad5220966ff41829eaa98be47046a04
Autor:
Kenshiro Hirata, Akito Kawai, Victor Tuan Giam Chuang, Keiki Sakurama, Koji Nishi, Keishi Yamasaki, Masaki Otagiri
Publikováno v:
ACS Omega, Vol 7, Iss 5, Pp 4413-4419 (2022)
Externí odkaz:
https://doaj.org/article/f99ee7371bde438d8a3267907352f9af
Publikováno v:
ACS Omega, Vol 4, Iss 5, Pp 8693-8700 (2019)
Externí odkaz:
https://doaj.org/article/ce06f0d501ac41989b3c430980c0854f
Autor:
Masaki Fukunaga, Daisuke Kadowaki, Mika Mori, Satomi Hagiwara, Yuki Narita, Junji Saruwatari, Ryota Tanaka, Hiroshi Watanabe, Keishi Yamasaki, Kazuaki Taguchi, Hiroki Ito, Toru Maruyama, Masaki Otagiri, Sumio Hirata
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0233925 (2020)
It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate
Externí odkaz:
https://doaj.org/article/0411000611ae4ea4a8b5c0f1f817187d
Autor:
Keiki Sakurama, Akito Kawai, Victor Tuan Giam Chuang, Yoko Kanamori, Miyu Osa, Kazuaki Taguchi, Hakaru Seo, Toru Maruyama, Shuhei Imoto, Keishi Yamasaki, Masaki Otagiri
Publikováno v:
ACS Omega, Vol 3, Iss 10, Pp 13790-13797 (2018)
Externí odkaz:
https://doaj.org/article/be5ffa2d551b4f0b8fa70732480f3651
Publikováno v:
Biochemistry and Biophysics Reports, Vol 14, Iss C, Pp 155-160 (2018)
It is well known that various physiological factors such as pH, endogenous substances or post-translational modifications can affect the conformational state of human serum albumin (HSA). In a previous study, we reported that both pH- and long chain
Externí odkaz:
https://doaj.org/article/74794110fec0470899bbbb0dd6cbf49b
Publikováno v:
Biochemistry and Biophysics Reports, Vol 13, Iss , Pp 78-82 (2018)
Sodium 4-phenylbutyrate (PB) is an orphan drug for the treatment of urea cycle disorders. It also inhibits the development of endoplasmic reticulum stress, the action of histone deacetylases and as a regulator of the hepatocanalicular transporter. PB
Externí odkaz:
https://doaj.org/article/c674fc1af16043119302209af11853cb
Autor:
Kazuaki Taguchi, Saori Nagao, Hitoshi Maeda, Hiroki Yanagisawa, Hiromi Sakai, Keishi Yamasaki, Tomohiko Wakayama, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1266-1274 (2018)
Macrophages play a central role in various inflammatory disorders and are broadly divided into two subpopulations, M1 and M2 macrophage. In the healing process in acute inflammatory disorders, shifting the production of M1 macrophages to M2 macrophag
Externí odkaz:
https://doaj.org/article/6ebbf1f1c909460fbcb25e9ee27d4a2f